Olanzapine Pamoate Patent Expiration
Olanzapine Pamoate is Used for treating psychosis in individuals. It was first introduced by Cheplapharm Registration Gmbh
Olanzapine Pamoate Patents
Given below is the list of patents protecting Olanzapine Pamoate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zyprexa Relprevv | US6169084 | 2-methyl-thieno-benzodiazepine formulation |
Sep 30, 2018
(Expired) | Cheplapharm |
Olanzapine Pamoate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List